Advocate on issues related to regulation of, access to, and reimbursement for regenerative medicine companies and products. Value Based Payment legislation. CMS policies regarding Value Based legislation. FDA appropriations. FDA staffing. Prescription Drug User Fee Act (PDUFA). Medicaid reimbursement. Provider credentialing. Medicare reimbursement. NTAP. Reintroduction of Medicaid VBPs for Patients (MVP) Act. Accelerating Kids Access to Care Act (S. 752 / H.R.1509). MDRP. CMMI. Give Kids a Chance Act (S. 932 / H.R. 1262). Rare Pediatric Disease Designation and Priority Review Voucher (PRV) Programs. Reintroduction of the Patient Access Act. Bipartisan Health Care Act (S. 891). NIH Funding.
Literal federal measure citations: S. 752, H.R.1509, S. 932, H.R. 1262, S. 891